Verapamil-d6
Verapamil-d6 ((±) -Verapamil-d6) is deuterium labeled Verapamil. Verapamil ((±) -Verapamil) is a calcium channel blocker and a potent and orally active first-generation P-glycoprotein (P-gp) inhibitor. Verapamil also inhibits CYP3A4. Verapamil has the potential for high blood pressure, heart arrhythmias and angina research[1][2][3].
Product Specifications
Product Name Alternative
(±) -Verapamil-d6; CP-16533-1-d6
UNSPSC
12352005
Target
Isotope-Labeled Compounds
Related Pathways
Others
Applications
Metabolism-protein/nucleotide metabolism
Field of Research
Metabolic Disease; Cancer; Cardiovascular Disease
Smiles
COC1=CC=C(C=C1OC)C(C(C([2H])([2H])[2H])C([2H])([2H])[2H])(CCCN(C)CCC2=CC=C(C(OC)=C2)OC)C#N
Molecular Formula
C27H32D6N2O4
Molecular Weight
460.64
References & Citations
[1]Russak EM, et al. Impact of Deuterium Substitution on the Pharmacokinetics of Pharmaceuticals. Ann Pharmacother. 2019;53 (2) :211-216.
Shipping Conditions
Room temperature
Scientific Category
Isotope-Labeled Compounds
Clinical Information
No Development Reported
Frequently Asked Questions
Explore Other Products
Browse additional items from our catalog
P21WAF1 (Tumor Suppressor Protein) (AC8), CF647 conjugate, 0.1mg/mL
